The present invention provides a novel endoglucanase nucleic acid sequence, designated egl7, and the corresponding EGVII amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding EGVII, recombinant EGVII proteins and methods for producing the same.
GOVERNMENT SUPPORT
[0001] Portions of this work were funded by Subcontract No. ZCO-30017-01 with the National Renewable Energy Laboratory under Prime Contract No. DE-AC36-99GO10337 with the U.S. Department of Energy. Accordingly, the United States Government may have certain rights in this invention.
CROSS REFERENCE TO RELATED APPLICATIONS
[0002] This application is a continuation of U.S. application Ser. No. 14/159,044, now U.S. Pat. No. 9,005,948, which is a continuation of U.S. application Ser. No. 13/920,043, now U.S. Pat. No. 8,658,406, which is a divisional of U.S. application Ser. No. 13/286,955, filed on Nov. 1, 2011, now U.S. Pat. No. 8,486,667, which is a continuation of U.S. application Ser. No. 12/250,316, filed on Oct. 13, 2008, now U.S. Pat. No. 8,114,655, which is a continuation of U.S. application Ser. No. 11/329,498, filed Jan. 10, 2006, now U.S. Pat. No. 7,449,319, which is a divisional of U.S. application Ser. No. 10/028,244, filed on Dec. 18, 2001, now U.S. Pat. No. 7,045,331.
